In This Issue
Stage Classification and Prediction of Prognosis
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
Review of Ongoing Clinical Trials in Non–Small-Cell Lung Cancer
Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial
Improving the Quality of Lung Cancer Care in Ontario
Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant
Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation
Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer
Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study
Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA(N2) Non–Small-Cell Lung Cancer
Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked
Thymidylate Synthase Expression and Outcome of Patients Receiving Pemetrexed for Advanced Nonsquamous Non–Small-Cell Lung Cancer in a Prospective Blinded Assessment Phase II Clinical Trial
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer
Combination of Mesothelin and CEA Significantly Improves the Differentiation between Malignant Pleural Mesothelioma, Benign Asbestos Disease, and Lung Cancer
Is Thymectomy Necessary in Nonmyasthenic Patients with Early Thymoma?
A Prospective Phase II Trial of Induction Chemotherapy with Docetaxel/Cisplatin for Masaoka Stage III/IV thymic Epithelial Tumors
Distinguishing Benign Thymic Lesions from Early-Stage Thymic Malignancies on Computed Tomography
Lung Adenocarcinoma with Ipsilateral Breast Metastasis
Combination Chemotherapy with Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung
Activity of Gefitinib in a Non–Small-Cell Lung Cancer Patient with Both Activating and Resistance EGFR Mutations
Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer
An Unusual Presentation of Malignant Pleural Mesothelioma
Recurrence of Malignant Pleural Mesothelioma at the Resection Borders—Local or Distant Recurrence?
Recurrence of Malignant Pleural Mesothelioma at the Resection Borders—Local or Distant Recurrence?
Are Prognostic Factors for Leptomeningeal Metastases Defined Sufficiently to Permit Tailored Treatment?
Interpretation of Anti-ALK Immunohistochemistry Results